19 July 2022AmericasSarah Speight
Haynes Boone hires top biotech patent lawyer
New partner boosts firm’s biotech practice | Move forms part of life sciences expansion | Role based at Washington, DC office.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Biotechnology
6 October 2021 Medical device company SurgiSil has persuaded the US Court of Appeals for the Federal Circuit that its application for a design patent covering a lip filler was erroneously rejected by the US Patent and Trademark Office.
Biotechnology
1 April 2021 Amgen v Sanofi continues the Federal Circuit’s trend of undermining certain antibody claims, explains Benjamin Pelletier of Haynes and Boone.
article
9 February 2023 The patent attorneys will be based in London and Birmingham.
Editor's picks
Editor's picks
Biotechnology
6 October 2021 Medical device company SurgiSil has persuaded the US Court of Appeals for the Federal Circuit that its application for a design patent covering a lip filler was erroneously rejected by the US Patent and Trademark Office.
Biotechnology
1 April 2021 Amgen v Sanofi continues the Federal Circuit’s trend of undermining certain antibody claims, explains Benjamin Pelletier of Haynes and Boone.
article
9 February 2023 The patent attorneys will be based in London and Birmingham.
Biotechnology
6 October 2021 Medical device company SurgiSil has persuaded the US Court of Appeals for the Federal Circuit that its application for a design patent covering a lip filler was erroneously rejected by the US Patent and Trademark Office.
Biotechnology
1 April 2021 Amgen v Sanofi continues the Federal Circuit’s trend of undermining certain antibody claims, explains Benjamin Pelletier of Haynes and Boone.
article
9 February 2023 The patent attorneys will be based in London and Birmingham.